IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Peer-Reviewed Research Paper
Ekkehard Schuetz, the Chief Science Officer at IMDx, reached a career milestone this week by publishing his 200th peer-reviewed research paper. This achievement marks a significant point in his tenure with the company, where he oversees scientific strategy and research initiatives.
Schuetz’s body of work spans several decades and focuses on clinical diagnostics and molecular biology. His research contributions frequently appear in medical and scientific journals, covering topics that range from diagnostic methodology to the application of genomic technologies in clinical settings. As the lead scientist at IMDx, Schuetz continues to direct the company’s internal research programs while maintaining his involvement in the broader academic community.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: June 29, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]





